Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

  title={Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis},
  author={Christopher JL Kevin Shunji Fablina Lucien Gisela Authia Chieh Murray Ikuta Sharara Swetschinski Robles Aguilar G and Christopher J. L. Murray and Kevin S Ikuta and Fablina Sharara and Lucien R Swetschinski and Gisela Robles Aguilar and Authia Gray and Chieh Han and Catherine Bisignano and Puja C. Rao and Eve Wool and Sarah C Johnson and Annie J. Browne and Michael Give Chipeta and Frederick Fell and Sean Hackett and Georgina Haines-Woodhouse and Bahar H Kashef Hamadani and Emmanuelle P. A. Kumaran and Barney McManigal and Ramesh Agarwal and Samuel O Akech and Samuel B. Albertson and John Amuasi and Jason R. Andrews and Aleskandr Aravkin and Elizabeth A Ashley and Freddie Bailey and Stephen Baker and Buddha Basnyat and Adrie Bekker and Rose G Bender and Adhisivam Bethou and Julia A. Bielicki and Suppawat Boonkasidecha and James Bukosia and Cristina G Carvalheiro and Carlos Casta{\~n}eda-Orjuela and Vilada Chansamouth and Suman Chaurasia and Sara Chiurchi{\'u} and Fazle Rabbi Chowdhury and Aislinn Cook and Ben S Cooper and Tim Roy Cressey and Elia Criollo-Mora and Matthew Cunningham and Saffiatou Darboe and Nicholas P. J. Day and Maia De Luca and Klara G. Dokova and Angela Dramowski and Susanna J . Dunachie and Tim Eckmanns and Daniel Eibach and Amir Hossein Emami and Nicholas A. Feasey and Natasha Fisher-Pearson and Karen Forrest and Denise Garrett and Petra Gastmeier and Ababi Zergaw Giref and Rachel Claire Greer and Vikas Gupta and Sebastian Haller and Andrea Haekyung Haselbeck and Simon I. Hay and Marianne Holm and Susan Hopkins and Kenneth Chukwuemeka Iregbu and Jan Jacobs and Daniel Jarovsky and Fatemeh Javanmardi and Meera Khorana and Niranjan Kissoon and Elsa Kobeissi and Tomislav Kostyanev and Fiorella Krapp and Ralf Krumkamp and Ajay Kumar and Hmwe H. Kyu and Cherry Lim and Direk Limmathurotsakul and Michael J. Loftus and Miles Lunn and Jianing Ma and Neema Mturi and Tatiana Múnera-Huertas and Patrick Musicha and Marisa M{\'a}rcia Mussi-Pinhata and Tomoka Nakamura and Ruchi Nimish Nanavati and Sushma Nangia and Paul N. Newton and Chanpheaktra Ngoun and Amanda Novotney and Davis Nwakanma and Christina W Obiero and Antonio Olivas-Mart{\'i}nez and Piero L Olliaro and Edna Ooko and Edgar Ortiz-Brizuela and Anton Y. Peleg and Carlo Perrone and Nishad Plakkal and Alfredo Ponce-de-Le{\'o}n and Mathieu Raad and Tanusha Ramdin and Amy Riddell and Tamalee Roberts and Julie V. Robotham and Anna Roca and Kristina E. Rudd and Neal J. Russell and Jesse Schnall and J. Anthony G. Scott and Madhusudhan Shivamallappa and Jos{\'e} Sifuentes-Osornio and Nicolas Steenkeste and Andrew J. Stewardson and Temenuga Stoeva and Nidanuch Tasak and Areerat Thaiprakong and Guy E. Thwaites and Claudia Turner and Paul Turner and H. Rogier van Doorn and Sithembiso C Velaphi and Avina Vongpradith and Huong X. Vu and Timothy Rutland Walsh and Seymour Waner and Tri Wangrangsimakul and Teresa M. Wozniak and Peng Zheng and Benn Sartorius and Alan D. Lopez and Andy S. Stergachis and Catrin E. Moore and Christiane Dolecek and Mohsen Naghavi},
  journal={Lancet (London, England)},
  pages={629 - 655}
  • Christopher JL Kevin Shunji Fablina Lucien Gisela Authia Chieh Murray Ikuta Sharara Swetschinski Robles Aguilar GC. Murray M. Naghavi
  • Published 1 January 2022
  • Medicine
  • Lancet (London, England)

Figures and Tables from this paper

Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now?

The SSA region is disproportionately affected by AMR, in part owing to the prevailing high levels of poverty, which result in a high burden of infectious diseases, poor regulation of antimicrobial use, and a lack of alternatives to ineffective antimicrobials.

Global and Regional Burden of Bacterial Antimicrobial Resistance in Urinary Tract Infections in 2019

AMR in UTI is an unignorable health problem, both for the management of urology disease and for global antibiotic resistance, and special tailored strategies should be developed for different regions according to the region-specific pathogen-antibiotic situations and resources.

Antimicrobial resistance: a major priority for global focus

  • J. Cooke
  • Medicine, Biology
    European journal of hospital pharmacy : science and practice
  • 2022
This special edition is dedicated to antimicrobial resistance (AMR) which has become a highly significant concern for governments and healthcare providers globally and covers a wide range of topics from authors worldwide.

Call for Papers: PLOS Medicine Special Issue on Bacterial Antimicrobial Resistance—Surveillance and Prevention

  • Medicine
    PLoS medicine
  • 2022
A forthcoming Special Issue dedicated to bacterial antimicrobial resistance (AMR), with areas of particular interest include the prevalence and clinical challenges of drug-resistant bacteria, interventions to reduce disease transmission, diagnostics informing antimicrobial prescribing, misuse and overuse of antimicrobials, economics of antimicrobial access and use, and One Health interventions to reduced AMR.

Excess Mortality Attributable to Hospital-Acquired Antimicrobial-Resistant Infections: A 2-Year Prospective Surveillance Study in Northeast Thailand

Estimating and monitoring excess mortality attributable to AMR infections should be included in national action plans to prioritize targets of preventive interventions, and urinary tract infections were associated with the highest number of deaths.

A Silent Pandemic of Antimicrobial Resistance: Challenges and Strategy for Preparedness in India

If AMR left unchecked, treatable infections will lead to huge increases in fatality from bacterial infections worldwide, unless drastic measures are taken today to counter this threat.



Antimicrobial resistance: a global multifaceted phenomenon

This review focuses on antibacterial resistance (ABR), which represents at the moment the major problem, both for the high rates of resistance observed in bacteria that cause common infections and for the complexity of the consequences of ABR.

Epidemiology and burden of multidrug-resistant bacterial infection in a developing country

It is demonstrated that national statistics on the epidemiology and burden of MDR in LMICs could be improved by integrating information from readily available databases after it was found that the prevalence and mortality attributable to M DR in Thailand are high.

Measuring and mapping the global burden of antimicrobial resistance

The inclusion of mortality and morbidity data related to drug-resistant infections into the annual Global Burden of Disease Study should help fill the evidence base to drive forward research and policy agendas to combat AMR.

Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage

It is suggested that global AMR gene diversity and abundance vary by region, and that improving sanitation and health could potentially limit the global burden of AMR.

Filling the gaps in the global prevalence map of clinical antimicrobial resistance

Estimating AMR prevalence worldwide allows for a data-driven prioritization of surveillance efforts and shows how structural surveillance investments can be prioritized based on the magnitude of prevalence estimated, the relative prevalence increase over 1998 to 2017, and the improvement of model performance achievable with new surveillance data.

Estimating the burden of antimicrobial resistance: a systematic literature review

This systematic review aimed to establish the alternative methodologies used in estimating AMR burden in order to appraise the current evidence base and highlight what methodological assumptions and biases can occur dependent on chosen outcome and perspective.

The role of vaccines in preventing bacterial antimicrobial resistance

The value of vaccines as an additional modality to combat AMR globally is highlighted, using select examples, and perspectives on how vaccines could be more effectively used in this effort are provided.

Burden of Antimicrobial Resistance: Compared to What?

The counterfactuals should be applied in cohort studies, whereby selection of the unexposed cohorts should be based on exposure density sampling, applying methods avoiding time-dependent bias and confounding, and guidance to harmonize methodologies and optimize study quality.